Search: (WFRF:(Schliep Alexander 1967)) >
De novo generated c...
De novo generated combinatorial library design
-
- Johansson, Simon, 1994 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för data- och informationsteknik (GU),Department of Computer Science and Engineering (GU),AstraZeneca AB,Chalmers tekniska högskola,Chalmers University of Technology,University of Gothenburg
-
- Haghir Chehreghani, Morteza, 1982 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för data- och informationsteknik (GU),Department of Computer Science and Engineering (GU),University of Gothenburg,Chalmers tekniska högskola,Chalmers University of Technology
-
- Engkvist, Ola, 1967 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för data- och informationsteknik (GU),Department of Computer Science and Engineering (GU),University of Gothenburg,Chalmers tekniska högskola,Chalmers University of Technology,AstraZeneca AB
-
show more...
-
- Schliep, Alexander, 1967 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för data- och informationsteknik (GU),Department of Computer Science and Engineering (GU),Chalmers tekniska högskola,Chalmers University of Technology,Brandenburgische Technische Universität Cottbus-Senftenberg,Brandenburg University of Technology Cottbus-Senftenberg,University of Gothenburg
-
show less...
-
(creator_code:org_t)
- 2024
- 2024
- English.
-
In: Digital Discovery. - 2635-098X. ; 3:1, s. 122-135
- Related links:
-
https://research.cha... (primary) (free)
-
show more...
-
https://gup.ub.gu.se...
-
https://doi.org/10.1...
-
https://research.cha...
-
show less...
Abstract
Subject headings
Close
- Artificial intelligence (AI) contributes new methods for designing compounds in drug discovery, ranging from de novo design models suggesting new molecular structures or optimizing existing leads to predictive models evaluating their toxicological properties. However, a limiting factor for the effectiveness of AI methods in drug discovery is the lack of access to high-quality data sets leading to a focus on approaches optimizing data generation. Combinatorial library design is a popular approach for bioactivity testing as a large number of molecules can be synthesized from a limited number of building blocks. We propose a framework for designing combinatorial libraries using a molecular generative model to generate building blocks de novo, followed by using k-determinantal point processes and Gibbs sampling to optimize a selection from the generated blocks. We explore optimization of biological activity, Quantitative Estimate of Drug-likeness (QED) and diversity and the trade-offs between them, both in single-objective and in multi-objective library design settings. Using retrosynthesis models to estimate building block availability, the proposed framework is able to explore the prospective benefit from expanding a stock of available building blocks by synthesis or by purchasing the preferred building blocks before designing a library. In simulation experiments with building block collections from all available commercial vendors near-optimal libraries could be found without synthesis of additional building blocks; in other simulation experiments we showed that even one synthesis step to increase the number of available building blocks could improve library designs when starting with an in-house building block collection of reasonable size.
Subject headings
- NATURVETENSKAP -- Data- och informationsvetenskap (hsv//swe)
- NATURAL SCIENCES -- Computer and Information Sciences (hsv//eng)
- SAMHÄLLSVETENSKAP -- Annan samhällsvetenskap -- Övrig annan samhällsvetenskap (hsv//swe)
- SOCIAL SCIENCES -- Other Social Sciences -- Other Social Sciences not elsewhere specified (hsv//eng)
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database